Clinical Trials Directory

Trials / Completed

CompletedNCT01890174

Repeatability and Reproducibility of Cirrus HD-OCT Macular Retinal Pigment Epithelium Elevation

Status
Completed
Phase
Study type
Observational
Enrollment
54 (actual)
Sponsor
Carl Zeiss Meditec, Inc. · Industry
Sex
All
Age
50 Years
Healthy volunteers
Not accepted

Summary

The objective of this study is to determine the repeatability and reproducibility of the Cirrus HD-OCT measurements of drusen area and volume.

Detailed description

This is a prospective, single site study. Ocular history and examination will be conducted on consented subjects to determine further participation in the study. The study will be divided into two phases. In Phase 1, the inter-device variability of Cirrus HD-OCT measurements of drusen area and volume will be determined. In Phase 2, the inter-operator variability of Cirrus HD-OCT measurements of drusen area and volume will be determined. In each of these phases, the Macular Cube 200 x 200 scan and the Macular Cube 512 x 128 scan will be evaluated.

Conditions

Timeline

Start date
2011-02-01
Primary completion
2011-06-01
Completion
2011-06-01
First posted
2013-07-01
Last updated
2013-07-01

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT01890174. Inclusion in this directory is not an endorsement.